Journals / Retina-Vitreus / 2015 / Cilt: 23 - Sayı: 0

Management of Retinopathy of Prematurity

Prematüre Retinopatisi Tedavisi

Pages
103–112
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purpose of this review is to provide an overview of the recent literature on ROP with a special focus on recent advances in treatment options

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Retinopathy of prematurity (ROP) is a potentially blinding disorder of premature infants.
📊
Key Findings & Data:With the increasing survival of premature infants, it is important to treat at-risk patients in a timely manner to preserve their visual function and reduce complications.
💡
Conclusion & Impact:The purpose of this review is to provide an overview of the recent literature on ROP with a special focus on recent advances in treatment options
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Retinopathy of prematurity (ROP) is a potentially blinding disorder of premature infants. With the increasing survival of premature infants, it is important to treat at-risk patients in a timely manner to preserve their visual function and reduce complications. The purpose of this review is to provide an overview of the recent literature on ROP with a special focus on recent advances in treatment options

Özet

Prematüre retinopatisi (ROP), prematüre bebeklerde körlüğe yol açabilen bir hastalıktır. Prematüre bebeklerin yaşama şansları giderek artmaktadır. Bu bebeklerde görmenin korunması ve komplikasyonların azalması için, riskli hastaların zamanında ve uygun bir şekilde tedavi edilmesi önemlidir. Bu derlemenin amacı ROP ile ilgili literatür bilgilerine dayanarak, güncel tedavi seçeneklerine genel bir bakış sağlamaktır

🔖

Cite This Article

EROL, N. (2015). Management of Retinopathy of Prematurity. Retina-Vitreus, Cilt: 23 - Sayı: 0, 103–112. https://ajindex.com/articles/304986

References (10)

  1. An international classification of retinopathy of prematurity. The com- mittee for the classification of retinopathy of prematurity. Arch Ophthal- mol 1984;102:1130-4. An international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005;123:991-9.
  2. Vander JF, Handa J, McNamara JA et al. Early treatment of poste- rior retinopathy of prematurity: a controlled trial. Ophthalmology 1997;104:1731-5.
  3. Shapiro MJ, Gieser JP, Warren KA et al. Zone I retinopathy of prematu- rity. In: Shapiro MJ, Biglan AW, Miller M. Retinopathy of Prematurity. Proceedings of the ınternational conference on retinopathy of prematu- rity. Chicago: Kugler Publications 1993:149-55.
  4. Kychenthal A, Dorta P, Katz X. Zone I retinopathy of prematurity: clini- cal characteristics and treatment outcomes. Retina 2006;26:11-5.
  5. Moshfeghi DM, Silva RA, Berrocal AM. Exudative retinal detachment following photocoagulation in older premature infants forretinopathy of prematurity: description and management. Retina. 2014;34:83-6. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multi- center trial of cryotherapy for retinopathy of prematurity. Arch Ophthal- mol 1988;106:471-9. Early Treatment for Retinopathy of Prematurity Cooperative Group. Re- vised indications for treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity Randomized Trial. Arch Ophthalmol 2003;121:1684-96.
  6. Katz X, Kychenthal A, Dorta P. Zone I retinopathy of prematurity. J AA- POS 2000;4:373-6. Early Treatment for Retinopathy of Prematurity Cooperative Group, Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Tung B, Redford M. Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol 2010;128:663-71.
  7. Christiansen SP, Dobson V, Quinn GE, et al. Progression of type 2 to type 1 retinopathy of prematurity in the Early Treatment for Retinopathy of Prematurity Study. Arch Ophthalmol 2010;128:461-5.
  8. Hu J, Blair MP, Shapiro MJ et al. Reactivation of retinopathy of prema- turity after bevacizumab injection. Arch Ophthalmol 2012;130:1000-6.
  9. Lee BJ, Kim JH, Heo H et al. Delayed onset atypical vitreoretinal tracti- on band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity. Eye 2012;26:903-9.
  10. Tahija SG, Hersetyati R, Lam GC et al. Fluorescein angiographic obser- vations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy